Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$1.1 - $2.17 $34,047 - $67,165
-30,952 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$1.99 - $3.1 $61,594 - $95,951
30,952 New
30,952 $62,000
Q2 2021

Aug 12, 2021

SELL
$2.56 - $3.35 $161,817 - $211,753
-63,210 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$2.01 - $5.05 $21,941 - $55,125
-10,916 Reduced 14.73%
63,210 $205,000
Q4 2020

Feb 25, 2021

BUY
$1.89 - $2.55 $140,098 - $189,021
74,126 New
74,126 $154,000

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.